The silver screen has been featuring more and more stories about people with disabilities, whether it be developmental, physical, or mental. With more representation in popular culture, comes more understanding […]
Sarepta Therapeutics announced topline results from EMBARK
Leading Duchenne Muscular Dystrophy Nonprofit Strengthens Leadership Team and Board Expertise
The Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation for AGAMREE’s approval in Europe.
– GRAND CANYON is the first pivotal study of an investigational therapy for Becker–– CANYON, the initial Phase 2 cohorts, is fully enrolled – BOULDER, Colo.–(BUSINESS WIRE)– Edgewise Therapeutics, Inc. (Nasdaq: […]
The “Afternoon in Palm Beach” Themed Event Raised Funds and Awareness for Duchenne Muscular Dystrophy AUSTIN, Texas (September 22, 2023) – Leading global nonprofit CureDuchenne held the annual Ladies Luncheon […]
See Previous News Release – Initiation of Phase 1 clinical trial marks Entrada’s transition into a clinical company – – Data anticipated in the second half of 2024 – BOSTON, […]
Funds Support Global Nonprofit’s Mission of Finding a Cure for Duchenne Muscular Dystrophy NEWPORT BEACH, Calif., (September 19, 2023) – CureDuchenne, a leading global nonprofit focused on finding and funding […]
NEWPORT BEACH, Calif., (September 19, 2023) — CureDuchenne, a leading nonprofit organization dedicated to advancing research and improving the lives of individuals affected by Duchenne muscular dystrophy, is proud to […]
